|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.50 USD | +2.48% |
|
-15.10% | -29.78% |
| 16/07 | RxSight Names Aziz Mottiwala as CEO | MT |
| 14/07 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| Market Cap | 247.39Cr 216.29Cr 199.53Cr 183.41Cr 347.53Cr 24TCr 353.47Cr 2.38TCr 934.63Cr 12TCr 929.04Cr 908.68Cr 40TCr | P/E 2026 * |
-25.6x | P/E 2027 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise Value | 247.39Cr 216.29Cr 199.53Cr 183.41Cr 347.53Cr 24TCr 353.47Cr 2.38TCr 934.63Cr 12TCr 929.04Cr 908.68Cr 40TCr | EV / Sales 2026 * |
3.47x | EV / Sales 2027 * | 2.75x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +2.48% | ||
| 1 week | -15.10% | ||
| Current month | -8.64% | ||
| 1 month | -7.03% | ||
| 3 months | -19.92% | ||
| 6 months | -21.93% | ||
| Current year | -29.78% |
| 1 week | 53.89 |  | 63.84 |
| 1 month | 53.89 | | 72.5 |
| Current year | 53.89 | | 83.92 |
| 1 year | 38.51 | | 85.25 |
| 3 years | 12.57 | | 85.25 |
| 5 years | 10.8 | | 85.25 |
| 10 years | 10.8 | | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06 | Free | Director | 6,254 | 0.0145% | ||
| 25/06 | Free | Director | 7,060 | 0.0164% | ||
| 25/06 | Free | Director | 6,254 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.48% | -15.10% | +41.70% | +225.78% | 247.39Cr | |
| +1.27% | +0.24% | +21.26% | -7.53% | 6.76TCr | |
| +1.38% | -5.23% | +38.08% | +197.15% | 5.13TCr | |
| +1.10% | +38.30% | +38.30% | +38.30% | 4.3TCr | |
| +0.94% | -2.18% | -50.38% | -52.56% | 4.08TCr | |
| +2.76% | -1.56% | +54.70% | -29.29% | 2.91TCr | |
| +1.25% | -7.48% | +116.21% | -43.73% | 2.71TCr | |
| +0.18% | -1.85% | +68.63% | +86.35% | 2.3TCr | |
| -2.63% | +9.44% | +9.63% | +200.00% | 2.16TCr | |
| -1.70% | +5.53% | +76.00% | +353.68% | 1.62TCr | |
| Average | +0.69% | -1.14% | +41.41% | +96.82% | 3.22TCr | |
| Weighted average by Cap. | +0.87% | -0.42% | +33.66% | +61.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 71Cr 62Cr 57Cr 53Cr 100.11Cr 6.86TCr 101.82Cr 686.18Cr 269.24Cr 3.35TCr 267.63Cr 261.76Cr 12TCr | 90Cr 79Cr 73Cr 67Cr 126.47Cr 8.66TCr 128.63Cr 866.87Cr 340.13Cr 4.23TCr 338.1Cr 330.69Cr 15TCr |
| Net income | -9.79Cr -8.56Cr -7.9Cr -7.26Cr -14Cr -942.13Cr -14Cr -94Cr -37Cr -460.49Cr -37Cr -36Cr -1.59TCr | 8.27Cr 7.23Cr 6.67Cr 6.13Cr 12Cr 795.95Cr 12Cr 80Cr 31Cr 389.04Cr 31Cr 30Cr 1.34TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/26/15 | $57.50 | +2.48% | 14,67,064 |
| 14/26/14 | $56.11 | -5.40% | 20,79,500 |
| 13/26/13 | $59.31 | +2.01% | 11,13,250 |
| 10/26/10 | $58.14 | -9.35% | 23,67,158 |
| 09/26/09 | $64.14 | -5.30% | 21,68,792 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
